RxDoctor Payments Data

Pamela Tittle

Physician Assistant · Anchorage, AKNPI 1417340282

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,702in general payments, 2019–2025

Across 263 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Sumitomo Pharma America, Inc.$685
  • Pfizer$425
  • AstraZeneca$404
  • E.r. Squibb & Sons, L.L.C.$315
  • Novartis$288
  • plus $3K from 54 others

What the payments were for

  • Food & beverage$6,54998%
  • Education$1532%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)39$1,133
Sumitomo Pharma America, Inc.22$685
Pfizer22$425
AstraZeneca(2 entities)18$404
E.r. Squibb & Sons, L.L.C.12$315
Novartis12$288
Seagen Inc.8$229
Daiichi Sankyo Inc.5$218
Astellas Pharma US Inc8$215
AbbVie8$178
AVEO Pharmaceuticals, Inc.4$166
Boehringer Ingelheim7$153
Accord Healthcare, Inc.4$153
180 Medical, Inc.5$129
Pharmacyclics LLC, An Abbvie Company5$121
Amgen5$120
Regeneron Healthcare Solutions, Inc.4$120
Endo USA, Inc.5$116
Bristol Myers Squibb4$101
Urogen Pharma, Inc.4$96
Coherus Oncology, Inc.4$76
Bayer4$73
Gilead3$64
EMD Serono, Inc.3$61
Myriad Genetic Laboratories, Inc.1$59
Blueprint Medicines Corporation2$50
Laborie Medical Technologies Corp.1$47
Deciphera Pharmaceuticals Inc.2$47
Ferring Pharmaceuticals Inc.2$45
Merck2$43
Beigene USA, Inc.2$40
Agios Pharmaceuticals, Inc.2$38
Incyte Corporation2$38
Eisai Inc.2$37
Sun Pharmaceutical Industries Inc.2$32
Acrotech Biopharma Inc.2$31
Ipsen Biopharmaceuticals, Inc1$30
GSK2$29
Taiho Oncology, Inc.1$28
Adaptive Biotechnologies Corporation1$27
Lilly USA, LLC1$25
Rigel Pharmaceuticals, Inc.1$25
ABC Home Medical Supply, Inc.1$25
G1 Therapeutics, Inc.1$24
Jazz Pharmaceuticals Inc.1$24
Sanofi1$24
Kyowa Kirin, Inc.1$22
Morphosys, US Inc.1$22
Chiesi USA, Inc.1$22
Spectrum Pharmaceuticals Inc.1$22
Olympus America Inc.1$22
Sobi, Inc1$21
Dendreon Pharmaceuticals LLC1$20
Puma Biotechnology, Inc.1$20
Mirati Therapeutics, Inc.1$20
Array Biopharma Inc1$18
Alnylam Pharmaceuticals Inc.1$18
Foundation Medicine, Inc.1$18
Myovant Sciences Inc.1$16
Servier Pharmaceuticals LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,702 in reported general payments places this provider in the 95th percentile of 365 physician assistant providers in Alaska.

See all physician assistant providers in Alaska

Medicare billing

Part B allowed, 2024
$376,442
Medicare patients
477
Services billed
23,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OrgovyxRelugolix258$664,439
ErleadaApalutamide24$340,310
XtandiEnzalutamide11$153,510
Tamsulosin Hcl91$1,240
Ciprofloxacin Hcl24$153
Oxybutynin Chloride ErOxybutynin Chloride12$86

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Orgovyx$685$664,439258 claims
Johnson & JohnsonErleada$1,133$340,31024 claims
Astellas Pharma US IncXtandi$215$153,51011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 365 physician assistant providers in Alaska.

Other physician assistant in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →